Validation, in a Pediatric Population, of a French Translation of the MEPS/MEPI Score
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-17
SponsorCentre Hospitalier Universitaire, Amiens
About this trial
The MEPI (Modified Elbow Performance Index) or MEPS (Modified Elbow Performance Score) is a multidimensional assessment scale for elbow pain and function. This score is widely used in scientific literature, particularly for post-traumatic and post-operative evaluation, including in many French-language studies. However, no French translation of this score has undergone quality criteria verification and validation in a pediatric population.
Eligibility criteria
Qualifiers
Patients aged 4 to 17 years followed in the department without an elbow injury
Follow-up schedule compatible with the study protocol
No objection from a parent or legal guardian, with the child's consent if age permits
Patients aged 4 to 17 years followed in the department with a diagnosis of an elbow injury
Disqualifiers
Language barrier, lack of understanding of French
Refusal to participate
Confounding factor impairing function
Opposition of parent or legal guardian and/or refusal of child if age permits
Trial design
Treatments tested in this trial
- MEPS-Fr version
Treatment groups
170 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov